Skip to main content
# Title Research Member Research Year
161 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2015
162 Strong association between long and heterogeneous
telomere length in blood lymphocytes and bladder
cancer risk in Egyptian
Prof. Douaa Mohamed Sayed Hussein 2015
163 Frequency of the ALK gene and its prognostic value in neuroblastoma by FISH‏ Prof. Mohamed Rafat / Mohammed Ibrahim Khalaf 2015
164 the immuno;ogical role monocyte and other cytokines in patients with breast cancer undergoing paravertebral analgesia Prof. Douaa Mohamed Sayed Hussein 2015
165 Prognostic implications of expression of the Wilms tumor 1 (WT1) gene in acute leukemia (Experience from South Egypt) Prof. Hosny Badrawy Hamed Omran 2015
166 Prognostic Value of KRAS Mutations in Codons 12 and 13 in South Egyptian Colorectal Cancer Patients Prof. Hosny Badrawy Hamed Omran 2015
167 Frequency of the ALK gene and its prognostic value in neuroblastoma by FISH‏ Prof. Eman Massad Zaki El-Hefny 2015
168 The role of Circulating Tumor Cells (CTCs) in
Predicting the Response of Primary (Neoadjuvant)
Chemotherapy and its Impact as a Prognostic Factor in
Early Breast Cancer









































Dr. Asmaa Mohamed Zahran Omar 2014
169 Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2014
170 Fms-Like Tyrosine Kinase 3 expression in Childhood Acute lymphoblastic Leukemia at South Egypt Cancer Institute, Assiut University, Egypt

Dr. Asmaa Mohamed Zahran Omar 2014